{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:18:00Z","timestamp":1793643480909,"version":"4.5.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","award":["2022-2023"],"award-info":[{"award-number":["2022-2023"]}],"id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT#1195713"],"award-info":[{"award-number":["GNT#1195713"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1194667"],"award-info":[{"award-number":["1194667"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.survophthal.2024.05.002","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T02:39:38Z","timestamp":1715395178000},"page":"665-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Gene and cell therapy for age-related macular degeneration: A review"],"prefix":"10.1016","volume":"69","author":[{"given":"Jos\u00e9","family":"Trinc\u00e3o-Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren N.","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron G.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Marques-Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn H.","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Cordeiro","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR tool kit for genome editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.survophthal.2024.05.002_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/BF00184273","article-title":"Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization","volume":"232","author":"Algvere","year":"1994","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.002_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/BF00941722","article-title":"Transplantation of RPE in age-related macular degeneration: Observations in disciform lesions and dry RPE atrophy","volume":"235","author":"Algvere","year":"1997","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.05.002_bib4","first-page":"277","article-title":"Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration","volume":"1997","author":"Allikmets","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2024.05.002_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-021-03796-9","article-title":"The complement system in age-related macular degeneration","volume":"Vol. 78","author":"Armento","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib6","volume":"131","author":"Arnold","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.05.002_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin - Tie system","volume":"Vol. 10","author":"Augustin","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"10.1016\/j.survophthal.2024.05.002_bib8","first-page":"6027","article-title":"Autologous Retinal Pigment Epithelium (RPE)-choroid sheet transplantation versus autologous RPE cell-suspension transplantation in patients with Age-Related Macular Degeneration (AMD) - clinical results","volume":"48","author":"Binder","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5235","key":"10.1016\/j.survophthal.2024.05.002_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years","volume":"270","author":"Blaese","year":"1979","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.2016.117","article-title":"Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study","volume":"28","author":"Campochiaro","year":"2023","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.002_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/hum.2006.17.167","article-title":"Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial","volume":"17","author":"Campochiaro","year":"2023","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.survophthal.2024.05.002_bib12","article-title":"Nutritional and lifestyle interventions for age-related macular degeneration: a review","volume":"2017","author":"Carneiro","year":"2023","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"10.1016\/j.survophthal.2024.05.002_bib13","first-page":"34","article-title":"Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration","author":"Chandra","year":"2020","journal-title":"Eye (Basingstoke)"},{"key":"10.1016\/j.survophthal.2024.05.002_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S269162","article-title":"Ten-year real-world outcomes of anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration","volume":"15","author":"Cheema","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.002_bib15","article-title":"Viral vectors for gene transfer","volume":"8","author":"Chen","year":"2018","journal-title":"Curr Protoc Mouse Biol"},{"issue":"8","key":"10.1016\/j.survophthal.2024.05.002_bib16","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.ophtha.2012.02.014","article-title":"Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections","volume":"119","author":"Cheung","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.002_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ajcn\/73.2.209","article-title":"Prospective study of dietary fat and the risk of age-related macular degeneration","volume":"73","author":"Cho","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.002_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration","volume":"36","author":"da Cruz","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2020.0437","article-title":"Incidence and progression of nongeographic atrophy in the comparison of age-related macular degeneration treatments trials (CATT) clinical trial","volume":"138","author":"Daniel","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-021-00239-9","article-title":"Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells","volume":"28","author":"Dreismann","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.survophthal.2024.05.002_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"Vol. 359","author":"Dunbar","year":"2018","journal-title":"Science"},{"issue":"7341","key":"10.1016\/j.survophthal.2024.05.002_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature09941","article-title":"Self-organizing optic-cup morphogenesis in three-dimensional culture","volume":"472","author":"Eiraku","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/IIO.0000000000000251","article-title":"Medical and surgical applications for the suprachoroidal space","volume":"59","author":"Emami-Naeini","year":"2019","journal-title":"Int Ophthalmol Clin"},{"issue":"20","key":"10.1016\/j.survophthal.2024.05.002_bib24","first-page":"1","article-title":"Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020","volume":"21","author":"Everts","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.survophthal.2024.05.002_bib25","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"Vol. 27","author":"Falavarjani","year":"2013","journal-title":"Eye (Basingstoke)"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.002_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/bjo.2009.176305","article-title":"Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study","volume":"95","author":"Falkner-Radler","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"4025","key":"10.1016\/j.survophthal.2024.05.002_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.175.4025.949","article-title":"Gene therapy for human genetic disease?","volume":"175","author":"Friedmann","year":"1979","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.002_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227641","article-title":"Fibrin hydrogels are safe, degradable scaffolds for sub-retinal implantation","volume":"15","author":"Gandhi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2024.05.002_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.actbio.2017.11.058","article-title":"Fibrin hydrogels as a xenofree and rapidly degradable support for transplantation of retinal pigment epithelium monolayers","volume":"67","author":"Gandhi","year":"2023","journal-title":"Acta Biomater"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.002_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jop.2021.0001","article-title":"Comprehensive preclinical assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema","volume":"37","author":"Gelfman","year":"2023","journal-title":"J Ocul Pharm Ther"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.002_bib32","doi-asserted-by":"crossref","DOI":"10.3109\/02713688509000857","article-title":"Transplantation of cultured human retinal epithelium to bruch\u2019s membrane of the owl monkey\u2019s Eye","volume":"4","author":"Gouras","year":"1985","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2024.05.002_bib33","unstructured":"Group A related EDSR. AREDS Report No. 8. Arch Ophthalmol. 2001;119."},{"key":"10.1016\/j.survophthal.2024.05.002_bib34","doi-asserted-by":"crossref","DOI":"10.1159\/000486145","article-title":"2018 update on intravitreal injections: euretina expert consensus recommendations","volume":"Vol. 239","author":"Grzybowski","year":"2018","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2024.05.002_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2020-316195","article-title":"Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions","volume":"Vol. 105","author":"de Guimaraes","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.002_bib36","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.03-1034","article-title":"In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells","volume":"45","author":"Haruta","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10089","key":"10.1016\/j.survophthal.2024.05.002_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)30979-0","article-title":"Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial","volume":"390","author":"Heier","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib38","first-page":"1","article-title":"Risk factors in the development of stem cell therapy","volume":"9","author":"Herberts","year":"2023","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.002_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2009.04.035","article-title":"Generation of retinal cells from mouse and human induced pluripotent stem cells","volume":"458","author":"Hirami","year":"2009","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.002_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 Trial","volume":"128","author":"Jaffe","year":"2023","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2024.05.002_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/archopht.1992.01080240039024","article-title":"Race, Macular Degeneration, and the Macular Photocoagulation Study","volume":"110","author":"Jampol","year":"1992","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2017-310368","article-title":"Prevalence of age-related macular degeneration in rural southern China: The Yangxi Eye Study","volume":"102","author":"Jin","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ophtha.2012.02.003","article-title":"Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study","volume":"119","author":"Kaiser","year":"2023","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2010.02.006","article-title":"RNAi-Based Treatment for Neovascular Age-Related Macular Degeneration by Sirna-027","volume":"150","author":"Kaiser","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"10(435","key":"10.1016\/j.survophthal.2024.05.002_bib45","article-title":"A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration","author":"Kashani","year":"2023","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.survophthal.2024.05.002_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2017.4182","article-title":"Prevalence of age-related macular degeneration in Australia: The Australian National Eye Health Survey","volume":"135","author":"Keel","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2024.05.002_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 Report Number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2024.05.002_bib48","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2018.144","article-title":"Dalkara D. Dosage Thresholds and Influence of Transgene Cassette in Adeno-Associated Virus-Related Toxicity","volume":"29","author":"Khabou","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.survophthal.2024.05.002_bib49","article-title":"Review of gene therapies for age-related macular degeneration","volume":"Vol. 36","author":"Khanani","year":"2022","journal-title":"Eye (Basingstoke)"},{"key":"10.1016\/j.survophthal.2024.05.002_bib50","doi-asserted-by":"crossref","DOI":"10.1159\/000432401","article-title":"Age-Related Macular Degeneration: A Complementopathy","volume":"Vol. 54","author":"Kijlstra","year":"2015","journal-title":"Ophthalmic Res"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.002_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau6732","article-title":"Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration","volume":"5","author":"Kim","year":"2019","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib52","first-page":"1","article-title":"Long-term safety evaluation of continuous intraocular delivery of aflibercept by the intravitreal gene therapy candidate ADVM-022 in nonhuman primates","volume":"10","author":"Kiss","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"5720","key":"10.1016\/j.survophthal.2024.05.002_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"1979","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.survophthal.2024.05.002_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2015.06.053","article-title":"Factors associated with recurrence of age-related macular degeneration after anti-vascular endothelial growth factor treatment: a retrospective cohort study","volume":"122","author":"Kuroda","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2024.05.002_bib55","first-page":"161","article-title":"Retinal pigment epithelial atrophy in neovascular age-related macular degeneration after ranibizumab treatment","author":"Kuroda","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib56","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ophtha.2012.02.002","article-title":"Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results","volume":"119","author":"Larsen","year":"2023","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.002_bib57","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.14-13897","article-title":"Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage","volume":"55","author":"Lee","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.002_bib58","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the planet study: a randomized clinical trial","volume":"136","author":"Lee","year":"2023","journal-title":"JAMA Ophthalmol ["},{"issue":"05","key":"10.1016\/j.survophthal.2024.05.002_bib59","doi-asserted-by":"crossref","DOI":"10.4172\/2327-5073.1000118","article-title":"Preventing intraocular infections after intravitreal injections: injection technique","volume":"02","author":"Leng","year":"2012","journal-title":"Clin Microbiol: Open Access"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.002_bib60","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1134\/S0006297916070063","article-title":"Viral Vectors for Gene Therapy: Current State and Clinical Perspectives","volume":"81","author":"Lukashev","year":"2016","journal-title":"Biochem (Mosc)"},{"key":"10.1016\/j.survophthal.2024.05.002_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10081785","article-title":"Trends of stem cell therapies in age-related macular degeneration","volume":"Vol. 10","author":"Maeda","year":"2021","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.survophthal.2024.05.002_bib62","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell\u2013derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2024.05.002_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2015.11.011","article-title":"Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: Implications for Age-related Macular Degeneration","volume":"7","author":"Marazita","year":"2016","journal-title":"Redox Biol"},{"issue":"8","key":"10.1016\/j.survophthal.2024.05.002_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015785","volume":"7","author":"Marques","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64601-4","article-title":"Polarization-sensitive optical coherence tomography for estimating relative melanin content of autologous induced stem-cell derived retinal pigment epithelium","volume":"10","author":"Matsuzaki","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.002_bib66","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e31820a67e4","article-title":"Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: Causative organisms and possible prevention strategies","volume":"31","author":"McCannel","year":"2011","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.survophthal.2024.05.002_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2018.04.037","article-title":"Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration","volume":"125","author":"Mehat","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.002_bib68","doi-asserted-by":"crossref","DOI":"10.1097\/IIO.0000000000000366","article-title":"Ocular inflammation and treatment emergent adverse events in retinal gene therapy","volume":"61","author":"Mehta","year":"2021","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.survophthal.2024.05.002_bib69","doi-asserted-by":"crossref","unstructured":"Milone M.C., O\u2019Doherty U. Clinical use of lentiviral vectors. Leukemia 2018 32:7 [Internet]. 2018 Mar 22 [cited 2023 Apr 29];32(7):1529\u20131541. doi:10.1038\/s41375\u2013018-0106\u20130.","DOI":"10.1038\/s41375-018-0106-0"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.002_bib70","article-title":"Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19","volume":"112","author":"Milton","year":"2005","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4252\/wjsc.v13.i5.366","article-title":"Stem cell therapy in ocular pathologies in the past 20 years","volume":"13","author":"Miotti","year":"2023","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.survophthal.2024.05.002_bib72","first-page":"10","article-title":"The suprachoroidal space: From potential space to a space with potential","author":"Moisseiev","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.002_bib73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1114","article-title":"Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization","volume":"188","author":"Mori","year":"2023","journal-title":"J Cell Physiol"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.002_bib74","first-page":"2428","article-title":"Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor","volume":"43","author":"Mori","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib75","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3390\/ijms23052850","article-title":"Stem cell therapy: from idea to clinical practice","volume":"Vol 23","author":"Mousaei Ghasroldasht","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2013.06.024","article-title":"Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography","volume":"156","author":"Nagiel","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.05.002_bib77","doi-asserted-by":"crossref","unstructured":"Osakada F., Ikeda H., Sasai Y., Takahashi M.. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc. 2009;4(6). doi:10.1038\/nprot.2009.51.","DOI":"10.1038\/nprot.2009.51"},{"key":"10.1016\/j.survophthal.2024.05.002_bib78","doi-asserted-by":"crossref","DOI":"10.1159\/000479157","article-title":"Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases","volume":"Vol. 58","author":"Peng","year":"2017","journal-title":"Ophthalmic Res"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.002_bib79","article-title":"A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring","volume":"22","author":"Peyman","year":"1991","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.survophthal.2024.05.002_bib80","doi-asserted-by":"crossref","unstructured":"Reichel F.F., Seitz I., Wozar F., et al. Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec. British Journal of Ophthalmology [Internet]. 2022 May 24 [cited 2023 Jul 1]; doi:10.1136\/BJOPHTHALMOL-2021\u2013321023.","DOI":"10.1136\/bjophthalmol-2021-321023"},{"issue":"10","key":"10.1016\/j.survophthal.2024.05.002_bib81","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.14-14246","article-title":"Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study","volume":"55","author":"Restrepo","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"21","key":"10.1016\/j.survophthal.2024.05.002_bib82","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddi353","article-title":"Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk","volume":"14","author":"Rivera","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.002_bib83","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin\u00ae) for neovascular age-related macular degeneration","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.survophthal.2024.05.002_bib84","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-1-4614-3209-8_55","article-title":"The complement regulatory protein CD59: insights into attenuation of choroidal neovascularization","volume":"801","author":"Schnabolk","year":"2023","journal-title":"Adv Exp Med Biol"},{"issue":"9967","key":"10.1016\/j.survophthal.2024.05.002_bib85","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: Follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2024.05.002_bib86","article-title":"Genetic factors associated with the development of age-related macular degeneration","volume":"Vol. 52","author":"Sergejeva","year":"2016","journal-title":"Med (Lith)"},{"key":"10.1016\/j.survophthal.2024.05.002_bib87","article-title":"Current state of human gene therapy: approved products and vectors","volume":"Vol. 16","author":"Shchaslyvyi","year":"2023","journal-title":"Pharm Multidiscip Digit Publ Inst (MDPI)"},{"issue":"27","key":"10.1016\/j.survophthal.2024.05.002_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1606","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles","volume":"6","author":"Shen","year":"2020","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.002_bib89","first-page":"E81","article-title":"Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration","volume":"113","author":"Shirai","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"10.1016\/j.survophthal.2024.05.002_bib90","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/10.23.2671","article-title":"Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration","volume":"10","author":"Shroyer","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2024.05.002_bib91","first-page":"80","article-title":"Efficacy and safety of intravitreal aflibercept treat and extend for polypoidal choroidal vasculopathy in the ATLANTIC study: a randomized clinical","author":"Silva","year":"2022","journal-title":"Trial"},{"key":"10.1016\/j.survophthal.2024.05.002_bib92","article-title":"SUMMIT: combination therapy with verteporfin pdt and ranibizumab for subfoveal choroidal neovascularization due to AMD","volume":"Vol. 48","author":"Slakter","year":"2007"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.002_bib93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/35038533","article-title":"Gene therapy: trials and tribulations","volume":"1","author":"Somia","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.002_bib94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2023","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.002_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072217","article-title":"HLA-matched allogeneic IPS cells-derived rpe transplantation for macular degeneration","volume":"9","author":"Sugita","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2024.05.002_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.oret.2019.04.021","article-title":"Evaluation of transplanted autologous induced pluripotent stem cell-derived retinal pigment epithelium in exudative age-related macular degeneration","author":"Takagi","year":"2019","journal-title":": Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2024.05.002_bib97","doi-asserted-by":"crossref","DOI":"10.2176\/nmc.ra.2020-0049","article-title":"Historic overview of genetic engineering technologies for human gene therapy","volume":"Vol. 60","author":"Tamura","year":"2020","journal-title":"Neurol Med-Chir"},{"issue":"31","key":"10.1016\/j.survophthal.2024.05.002_bib98","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1523061113","article-title":"Protective responses to sublytic complement in the retinal pigment epithelium","volume":"113","author":"Tan","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2024.05.002_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/sj.eye.6701978","article-title":"Smoking and age-related macular degeneration: A review of association","volume":"Vol. 19","author":"Thornton","year":"2005","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.survophthal.2024.05.002_bib100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.oret.2019.03.013","article-title":"Current practice preferences and safety protocols for intravitreal injection of anti-vascular endothelial growth factor agents","volume":"3","author":"Uhr","year":"2023","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2024.05.002_bib101","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2017.150","article-title":"Unraveling the complex story of immune responses to AAV vectors trial after trial","volume":"Vol. 28","author":"Vandamme","year":"2017","journal-title":"Hum Gene Ther"},{"issue":"88","key":"10.1016\/j.survophthal.2024.05.002_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002103","article-title":"Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey","volume":"3","author":"Vandenberghe","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.survophthal.2024.05.002_bib103","first-page":"445","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy: Current management and clinical trials","author":"Varela","year":"2022"},{"key":"10.1016\/j.survophthal.2024.05.002_bib104","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/895147","article-title":"Smoking and age-related macular degeneration: Review and update","volume":"Vol. 2013","author":"Velilla","year":"2013","journal-title":"J Ophthalmol"},{"issue":"6059","key":"10.1016\/j.survophthal.2024.05.002_bib105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/320225a0","article-title":"The ethics of human gene therapy","volume":"320","author":"Walters","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.002_bib106","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.survophthal.2024.05.002_bib107","article-title":"Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy","volume":"19","author":"Weisz","year":"1999","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2024.05.002_bib108","article-title":"Prevalence of age-related macular degeneration in an elderly UK Caucasian population - The Bridlington Eye Assessment Project: A cross-sectional study","author":"Wilde","year":"2017","journal-title":": Eye (Basingstoke)"},{"key":"10.1016\/j.survophthal.2024.05.002_bib109","first-page":"186","article-title":"Choroidal changes after suprachoroidal injection of triamcinolone acetonide in eyes with macular edema secondary to retinal vein occlusion","author":"Willoughby","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2024.05.002_bib110","doi-asserted-by":"crossref","unstructured":"Witkin A.J., Jaffe G.J., Srivastava S.K., Davis J.L., Kim J.E. Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics ( ReST) Committee. 2024; doi:10.1177\/24741264231220224.","DOI":"10.1177\/24741264231220224"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.002_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.survophthal.2024.05.002_bib112","doi-asserted-by":"crossref","unstructured":"Writing Group for the ARG, Bonds DE, Harrington M, et al. Effect of long-chain omega-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA Intern Med. 2014;174(5).","DOI":"10.1001\/jamainternmed.2014.328"},{"key":"10.1016\/j.survophthal.2024.05.002_bib113","first-page":"14","article-title":"Inhibition of retinal neovascularization by siRNA targeting VEGF165","author":"Xia","year":"2008","journal-title":"Mol Vis"},{"issue":"9","key":"10.1016\/j.survophthal.2024.05.002_bib114","article-title":"Technique of retinal gene therapy: Delivery of viral vector into the subretinal space","volume":"31","author":"Xue","year":"2017","journal-title":"Eye (Basingstoke)"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.002_bib115","article-title":"Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration. Retina","volume":"34","author":"Young","year":"2014"},{"issue":"9","key":"10.1016\/j.survophthal.2024.05.002_bib116","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.76.9.4580-4590.2002","article-title":"Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors","volume":"76","author":"Zaiss","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.survophthal.2024.05.002_bib117","unstructured":"ARMS2 age-related maculopathy susceptibility 2 [Homo sapiens (human)] - Gene - NCBI [Internet]. [cited 2023 May 25]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/387715."},{"key":"10.1016\/j.survophthal.2024.05.002_bib118","unstructured":"FDA Approves SYFOVRETM (pegcetacoplan injection) as the First and Only Treatment for Geographic Atrophy (GA), a Leading Cause of Blindness - Apellis Pharmaceuticals, Inc. [Internet]. [cited 2023 May 1]. Available from: https:\/\/investors.apellis.com\/news-releases\/news-release-details\/fda-approves-syfovretm-pegcetacoplan-injection-first-and-only."},{"key":"10.1016\/j.survophthal.2024.05.002_bib119","unstructured":"Avalanche Biotech Announces Positive Top-Line Phase IIa Results For AVA-101 In Wet Age-Related Macular Degeneration | BioSpace [Internet]. [cited 2023 Jun 14]. Available from: https:\/\/www.biospace.com\/article\/releases\/avalanche-biotech-announces-positive-top-line-phase-iia-results-for-ava-101-in-wet-age-related-macular-degeneration-\/."},{"key":"10.1016\/j.survophthal.2024.05.002_bib120","unstructured":"Adverum Biotechnologies, Inc. - Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single Intravitreal Injection of Ixo-vec (ADVM-022) [Internet]. [cited 2023 May 26]. Available from: https:\/\/investors.adverum.com\/news\/news-details\/2022\/Adverum-Biotechnologies-Presents-Positive-End-of-Study-Results-from-the-OPTIC-Trial-in-Wet-AMD-Including-Two-Year-Outcomes-Following-a-Single-Intravitreal-Injection-of-Ixo-vec-ADVM-022\/default.aspx#."},{"key":"10.1016\/j.survophthal.2024.05.002_bib121","unstructured":"REGENXBIO Presents Interim Data from Phase II Bridging Study Evaluating the Clinical Performance of RGX-314 Using the NAVXpressTM Manufacturing Platform Process | Regenxbio Inc [Internet]. [cited 2023 May 25]. Available from: https:\/\/regenxbio.gcs-web.com\/news-releases\/news-release-details\/regenxbio-presents-interim-data-phase-ii-bridging-study."},{"key":"10.1016\/j.survophthal.2024.05.002_bib122","unstructured":"Gyroscope Therapeutics Announces Positive Interim Data from Phase I\/II FOCUS Trial of Investigational Gene Therapy GT005 - Gyroscope [Internet]. [cited 2023 May 26]. Available from: https:\/\/www.gyroscopetx.com\/gyroscope-therapeutics-announces-positive-interim-data-from-phase-i-ii-focus-trial-of-investigational-gene-therapy-gt005\/."},{"key":"10.1016\/j.survophthal.2024.05.002_bib123","unstructured":"Janssen Announces Late-Breaking Data from Two Gene Therapy Programs at the American Academy of Ophthalmology 2022 Annual Meeting | Johnson & Johnson [Internet]. [cited 2023 May 26]. Available from: https:\/\/www.jnj.com\/janssen-announces-late-breaking-data-from-two-gene-therapy-programs-at-the-american-academy-of-ophthalmology-2022-annual-meeting."},{"key":"10.1016\/j.survophthal.2024.05.002_bib124","unstructured":"Controversies in Treatment Approaches: Gene Therapy, IVF, Stem Cells, and Pharmacogenomics | Learn Science at Scitable [Internet]. [cited 2023 Feb 1]. Available from: https:\/\/www.nature.com\/scitable\/topicpage\/controversies-in-treatment-approaches-gene-therapy-ivf-792\/."},{"key":"10.1016\/j.survophthal.2024.05.002_bib125","unstructured":"RG6501 (OpRegen\u00ae) Phase 1\/2a Clinical Results Support the Potential for OpRegen to Slow, Stop or Reverse Disease Progression in Geographic Atrophy Secondary to Age-Related Macular Degeneration | Lineage Cell Therapeutics, Inc. [Internet]. [cited 2023 Apr 30]. Available from: https:\/\/investor.lineagecell.com\/news-releases\/news-release-details\/rg6501-opregenr-phase-12a-clinical-results-support-potential-0."}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:39:23Z","timestamp":1778636363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625724000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":125,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0039625724000493"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.05.002","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene and cell therapy for age-related macular degeneration: A review","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}